Clinical Trial Update: BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies [EARLY_Phase 1]

View source ↗

Summary

Notes an early Phase 1 trial of BGT007 for recurrent or refractory gastrointestinal cancers, including colorectal and pancreatic cancers, which is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• BGT007

Snippet

Sponsor: BioSyngen Pte Ltd | Conditions: Colorectal Cancer, Pancreatic Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING